Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06238609 · ClinicalTrials.gov registry record · NA
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
A NA study of Muscle Weakness and Muscle Atrophy, sponsored by Bijan Najafi, PhD.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06238609 is a NA study of Muscle Weakness and Muscle Atrophy that is active but no longer recruiting, run by Bijan Najafi, PhD. The registered enrollment target is 25 participants, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06238609, a NA study of Muscle Weakness and Muscle Atrophy, is active but no longer recruiting, sponsored by Bijan Najafi, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Post-intensive care syndrome (PICS) encompasses persistent physical, cognitive, and psychiatric symptoms following ICU discharge, commonly triggered by serious conditions such as respiratory failure, sepsis, and mechanical ventilation. PICS prevalence is reported to be as high as 84% up to 12 months in patients with at least 2 days spent in the ICU or with mechanical ventilatory support. As a consequence, many patients do not return to they former level of function for weeks, months and even years. Muscular affection manifested by muscle weakness is particularly seen and is provoked by a combination of damage to the nerves or directly the muscles fibers. This affection is referred to as CU-Acquired Weakness (ICUAW). One third of the time, lower extremities are affected, often due to prolonged immobilization or sedation. Evidence suggests that early mobilization reduces the incidence of ICUAW at discharge and improves the number of patients able of stand. However achieving this early intervention is not always feasible due to time or personnel constraints. The purpose of the study is to examine the effectiveness of lower extremity neuromodulation for prevention of muscle deconditioning in patients admitted to the ICU.
Conditions Studied
Interventions
- DEVICE Intervention Group
- DEVICE Control Group
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-08-28 |
| Est. Completion | 2025-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06238609
The ClinicalTrials.gov registry entry for NCT06238609 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (66% lower). The listed sponsor is Bijan Najafi, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which Intervention Group is the first listed.
NCT06238609 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06238609 about?
NCT06238609 is a clinical study titled "Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome". Post-intensive care syndrome (PICS) encompasses persistent physical, cognitive, and psychiatric symptoms following ICU discharge, commonly triggered by serious conditions such as respiratory failure, sepsis, and mechanical ventilation. PICS prevalence is reported to be as high as 84% up to 12 months...
What is the current status of trial NCT06238609?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-08-28. Estimated completion is 2025-08-28.
What conditions does trial NCT06238609 study?
This clinical trial studies the following conditions: Muscle Weakness, Muscle Atrophy, Blood Flow.
What interventions are being tested in trial NCT06238609?
The interventions under investigation include: Intervention Group (DEVICE), Control Group (DEVICE).
Who is sponsoring clinical trial NCT06238609?
This trial is sponsored by Bijan Najafi, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06238609 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RECRUITING · NA
-
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RECRUITING · NA
-
Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
ACTIVE NOT RECRUITING · NA
-
HIFEM and Radiofrequency for Muscular System Function Improvement
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.